Fundraising Fox
/Companies
Sign in

アルファフュージョン

3 known investors

Find your way into アルファフュージョン

Sign up to see every warm intro you have to アルファフュージョン

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the アルファフュージョン team. We find them
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Alpha Fusion is a Japanese biotechnology company developing targeted alpha therapy drugs based on Astatine-211 (211At) to treat cancer with reduced side effects to healthy tissue.

BiotechDigital Health

Investors · 3

Kobe University Capitallisted by Kobe University CapitalKobe
OSAKA University Venture Capitallisted by OSAKA University Venture CapitalOsaka

Related companies · 1

Alpha RingAlpha Ring develops micro-fusion technology using proton-boron fusion reactions to generate clean energy for sectors including energy, healthcare, education, and heavy industry. The company designs compact, decentralized systems intended to accelerate commercial fusion deployment globally.

Companies working in the same space as アルファフュージョン.

Frequently asked questions

What does アルファフュージョン do?
Alpha Fusion is a Japanese biotechnology company developing targeted alpha therapy drugs based on Astatine-211 (211At) to treat cancer with reduced side effects to healthy tissue.
Who are アルファフュージョン's investors?
アルファフュージョン's investors include Global Brain, Kobe University Capital, OSAKA University Venture Capital.